Prevalence of nephrolithiasis in polycystic kidney disease

• Authors: Alma Idrizi , Myftar Barbullushi , Margarita Gjata , Alketa Koroshi , Enver Roshi , Teuta Backa , Sulejman Kodra , Nestor Thereska
• Languages of publication: EN

Abstracts

EN

We aim to define the prevalence of nephrolithiasis, the impact of anatomic and metabolic factors to stone formation and prognosis of patients with autosomal dominant polycystic kidney disease in Albania. We included 200 patients with autosomal dominant polycystic kidney from 2002 to 2009. The patients underwent X-ray, renal ultrasonography. We performed the metabolic evaluation of blood and urine. Survival times were calculated as the time to dialysis, transplantation, or death. Kaplan-Meier product-limit survival curves were constructed. Log rank test was used to compare the survival curves. Nephrolithiasis was present in 116 of our patients with autosomal dominant polycystic kidney disease (58%), with a mean age 46.4±5.7 years. Sixty five patients with kidney stones (56%) were women. The stones were composed primarily of urate (47%) and calcium oxalate (39%), and other compounds 14%. In 40% of patients the presence of stones was associated with a history of urinary tract infections and flank pain. In our study the prevalence of nephrolithiasis is 58%, higher than it reported in literature. Except anatomic and metabolic factors, there are other contributor factors to stone formation in our patients such socioeconomic status of patients, geographic zones and dietary habits.

Keywords

EN

Autosomal dominant polycystic kidney disease; Gross hematuria; Metabolic factors; Nephrolithiasis; Urinary tract infections

• Publisher: De Gruyter Open
• Journal: Open Medicine
• Year: 2011
• Volume: 6
• Issue: 4
• Pages: 497-501

Dates

published

1 - 8 - 2011

online

1 - 6 - 2011

Contributors

author

Alma Idrizi

• Service of Nephrology, UHC “Mother Teresa”, Tirana, Albania

author

Myftar Barbullushi

• Service of Nephrology, UHC “Mother Teresa”, Tirana, Albania

author

Margarita Gjata

• Service of Internal Medicine, UHC “Mother Teresa”, Tirana, Albania

author

Alketa Koroshi

• Service of Nephrology, UHC “Mother Teresa”, Tirana, Albania

author

Enver Roshi

• Department of Public Health, UHC “Mother Teresa”, Tirana, Albania

author

Teuta Backa

• Department of Internal Medicine, UHC “Mother Teresa”, Tirana, Albania

author

Sulejman Kodra

• Service of Nephrology, UHC “Mother Teresa”, Tirana, Albania

author

Nestor Thereska

• Service of Nephrology, UHC “Mother Teresa”, Tirana, Albania

References

• [1] Wilson PD, Goilav B. Cystic disease of the kidney. Annu Rev Pathol Mech Dis 2: 341–368, 2007 http://dx.doi.org/10.1146/annurev.pathol.2.010506.091850[Crossref]
• [2] Simon HB, Thompson GJ. Congenital renal polycystic disease. JAMA 159: 657–662, 1955
• [3] Milutinovic J, Fialkow PJ, Agodoa LY et al. Autosomal dominant polycystic kidney disease: Symptoms and clinical findings. Q J Med 212: 511–522, 1984
• [4] Delaney VB, Adler S, Bruns FJ et al. Autosomal dominant polycystic kidney disease: Presentation, complications and prognosis. Am J Kidney Dis 5: 104–111, 1985 [Crossref]
• [5] Torres WE, Wilson DM, Hattery RR, Segura JW. Renal stones disease in autosomal dominant polycystic kidney disease. Am J Kidney Dis 22: 513–519, 1993 [PubMed][Crossref]
• [6] Levine E, Grantham JJ. Calcified renal stones and cyst calcification in autosomal dominant polycystic kidney disease: Clinical and CT study in 84 patients. Am J Roentgenol 159: 77–81, 1992
• [7] Dalgaard OZ. Bilateral polycystic disease of the kidneys: a follow-up of two hundred and eighty four patients and their families. Acta Med Scand 328(S): 255–256, 1957
• [8] Segal AJ, Spataro RF, Barbaric ZL. Adult polycystic kidney disease: a review of 100 cases. J Urol 118: 711–713, 1967
• [9] Gambaro G, Fabris A, Puliatta D, Lupo A. Lithiasis in cystic kidney disease and malformations of the urinary tract. Urol Res 34: 102–107, 2006 http://dx.doi.org/10.1007/s00240-005-0019-z[Crossref]
• [10] Torres WE, Erickson SB, Smith LH, Wilson DM et al. The association of nephrolithiasis and autosomal dominant polycystic kidney disease. Am J Kidney Dis 11: 318–325, 1988 [Crossref][PubMed]
• [11] Ravine D, Gibson RN, Walker RG, Sheffield LJ, Kincaid-Smith P, Danks DM. Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease. Lancet 2: 824–827, 1994 http://dx.doi.org/10.1016/S0140-6736(94)92026-5[Crossref]
• [12] Sallée M, Rafat C, Zahar JR, Paulmier B, Grünfeld JP, Knebelmann B, Fakhouri F. Cyst Infections in Patients with Autosomal Dominant Polycystic Kidney Disease. Clin J Am Soc Nephrol 4: 1183–1189, 2009 http://dx.doi.org/10.2215/CJN.01870309[Crossref]
• [13] Levy FL, Adams-Huet B, Pak CYC: Ambulatory evaluation of nephrolithiasis: An update from 1980. Am J Med 98: 50–59, 1995 http://dx.doi.org/10.1016/S0002-9343(99)80080-1[Crossref]
• [14] Heilberg IP, Boim MA, Schor N. Biochemical differences between stone formers and normal subjects. In: Stone Disease: 1st International Consultation on Stone Disease, 21st Ed., edited by Segura J, Conort P, Khoury S, Pak C, Preminger GM, Tolley D, France, Health Publications 61–64, 2003
• [15] Statisical Analysis System, Cary, NC, SAS Institute Inc 1996
• [16] Cox DR: Regression models and life tables. J R Stat Soc B34: 187–220, 1972
• [17] Grampsas SA, Chandhoke PS, Fan J et al. Anatomic and metabolic risk factors for nephrolithiasis in patients with autosomal dominant polycystic kidney disease. Am J Kidney Dis 36(1): 53–57, 2000 http://dx.doi.org/10.1053/ajkd.2000.8266[Crossref]
• [18] Torres VE, Harris C, Pirson Y. Autosomal dominant polycystic kidney disease. Lancet 369: 1287–1301, 2007 http://dx.doi.org/10.1016/S0140-6736(07)60601-1[Crossref]
• [19] Nishiura JL, Neves RFCA, Eloi SRM, Cintra SMLF, Ajzen SA, Heilberg IP. Evaluation of Nephrolithiasis in Autosomal Dominant Polycystic Kidney Disease Patients. Clin J Am Soc Nephrol 4: 838–844, 2009 http://dx.doi.org/10.2215/CJN.03100608[Crossref]
• [20] Jackman SV, Potter SR, Regan F, Jarrett TW. Plain abdominal x-ray versus computerized tomography screening: sensitivity for stone localization after nonenhanced spiral computerized tomography. J Urol 164(2): 308–310, 2000 http://dx.doi.org/10.1016/S0022-5347(05)67346-6[Crossref]
• [21] Gabow PA, Duley I, Johnson AM. Clinical profiles of gross hematuria in autosomal dominant polycystic kidney disease. Am J Kidney Dis 20: 140–143, 1992 [Crossref][PubMed]
• [22] Gabow PA, Johnson AM, Kaehny WD, Kimberling WJ, Lezotte DC, Duley IT, Jones RH: Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease. Kidney Int 41: 1311–1319, 1992 http://dx.doi.org/10.1038/ki.1992.195[Crossref]
• [23] Johnson AM, Gabow PA: Identification of patients with autosomal dominant polycystic kidney disease at highest risk for end-stage renal disease. J Am Soc Nephrol 8: 1560–1567, 1997

Identifiers

DOI

10.2478/s11536-011-0043-z